Tanvex BioPharma, Inc. announced the appointment of James Williamson as Accounting Officer, effective February 6, 2024. James Williamson is VP of Finance of Tanvex BioPharma USA, Inc.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
42.35 TWD | +4.05% | +6.41% | -34.95% |
May. 28 | Tanvex BioPharma, Inc.(TWSE:6541) dropped from S&P Global BMI Index | CI |
May. 13 | Tanvex BioPharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-34.95% | 214M | |
+18.77% | 125B | |
+14.05% | 108B | |
-7.16% | 24.21B | |
+2.07% | 22.78B | |
-10.79% | 17.96B | |
-41.74% | 16.43B | |
-13.47% | 16.37B | |
+2.23% | 13.58B | |
+27.13% | 11.66B |
- Stock Market
- Equities
- 6541 Stock
- News Tanvex BioPharma, Inc.
- Tanvex BioPharma, Inc. Announces the Appointment of James Williamson as Accounting Officer